Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development

Selling and marketing

General and administrative

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Progenity

Biora Therapeutics, Inc. engages in the provision of molecular and specialized diagnostic tests to clinicians. Its products include the Preparent Carrier Test, Innatal Prenatal Screen, Riscover Hereditary Cancer Test, and Resura Prenatal Test. The company was founded by Paul W. Hawran and Harry Stylli in 2010 and is headquartered in San Diego, CA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Progenity, Inc. (NASDAQ: PROG) pursuant and/or traceable to the Company’s initial public offering conducted in June 2020 (the “IPO”) of the important October 27, 2020 lead plaintiff deadline in the case.

ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Reminds Progenity, Inc. Investors of Important Deadline in Securities Class Action – PROG

NEW YORK, Sept. 14, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Progenity, Inc.

ROSEN, A TOP RANKED LAW FIRM, Reminds Progenity, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - PROG

New York, New York--(Newsfile Corp. - September 14, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Progenity, Inc.

Progenity Investor Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Progenity, Inc. To Contact The Firm

ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Progenity, Inc. Investors of Important Deadline in Securities Class Action – PROG

NEW YORK and SAN DIEGO, Sept. 10, 2020 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein") announces that a federal securities class action lawsuit has been filed against Progenity, Inc.

PROGENITY, INC. CLASS ACTION ALERT: WOLF HALDENSTEIN ADLER FREEMAN & HERZ LLP ANNOUNCES THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN FILED ON BEHALF OF SHAREHOLDERS OF PROGENITY, INC.

LOS ANGELES, Sept. 9, 2020 /PRNewswire/ -- The Law Offices of Frank R.

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Progenity, Inc.

New York, New York--(Newsfile Corp. - September 4, 2020) -  Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Progenity, Inc.

Rosen, A Highly Recognized Law Firm, Announces Filing of Securities Class Action Lawsuit Against Progenity, Inc.; Encourages Investors with Losses in Excess of $100K to Contact Firm - PROG

NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Progenity, Inc. ("Progenity" or "the Company") (NASDAQ: PROG) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Progenity common stock pursuant and/or traceable to the registration statement, as amended (the "Registration Statement"), issued in connection with Progenity’s June 2020 initial public offering ("IPO").

PROG Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Progenity, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: October 27, 2020

SAN DIEGO--(BUSINESS WIRE)---- $PROG #ClassAction--Shareholder rights law firm Robbins LLP announces that a class action complaint was filed against Progenity, Inc. (NASDAQ: PROG) on behalf of shareholders who acquired Progenity, Inc.

Robbins LLP Announces Progenity, Inc. (PROG) Sued for Misleading Shareholders

NEW YORK--(BUSINESS WIRE)---- $PROG #classaction--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of California on behalf of those who acquired Progenity, Inc.

INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Progenity, Inc.

New York, New York--(Newsfile Corp. - September 1, 2020) -  Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Progenity, Inc.

PROG Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Progenity, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: October 27, 2020

NEW YORK--(BUSINESS WIRE)--Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the securities of Progenity, Inc. (“Progenity” or the “Company”) (NASDAQ: PROG) in the United States between June 19, 2020 and August 28, 2020 (the “Class Period”).

PROG SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit has been Filed Against Progenity, Inc.

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Progenity, Inc. (NASDAQ: PROG) pursuant and/or traceable to the Company’s initial public offering conducted in June 2020 (the “IPO” or “Offering”).

EQUITY ALERT: ROSEN, A LEADING NATIONAL FIRM, Announces Filing of Securities Class Action Lawsuit Against Progenity, Inc. – PROG

New York, New York--(Newsfile Corp. - August 30, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Progenity, Inc.

Progenity Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Progenity, Inc. To Contact The Firm

Los Angeles, California--(Newsfile Corp. - August 27, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Progenity, Inc.

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Progenity, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)---- $PROG #classaction--The Law Offices of Frank R. Cruz announces an investigation on behalf of Progenity, Inc.

The Law Offices of Frank R. Cruz Announces Investigation of Progenity, Inc.

SAN DIEGO--(BUSINESS WIRE)---- $PROG #ClassAction--Shareholder rights law firm Robbins LLP is investigating whether certain officers and directors of Progenity, Inc. (NASDAQ: PROG) breached their fiduciary duties to shareholders, misled the market, or violated federal securities laws in connection with its initial public offering ("IPO").

Robbins LLP Is Investigating the Officers and Directors of Progenity, Inc. (PROG) on Behalf of Shareholders

SAN DIEGO, Aug.  21, 2020  (GLOBE NEWSWIRE) --  Progenity, Inc.  (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products including NIPT, commends the recent guideline update from the American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM) recommending that all pregnant patients be offered aneuploidy screening, regardless of age or risk factors. This recommendation was featured in the new ACOG  Practice Bulletin 226  – Clinical Management Guidelines for Obstetrician-Gynecologists: Screening for Fetal Chromosomal Abnormalities, which replaces Practice Bulletin 163.

Progenity Commends New Recommendations from ACOG and SMFM Supporting Non-Invasive Prenatal Testing (NIPT) for All Pregnancies

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Progenity, Inc. (NASDAQ:PROG) resulting from allegations that Progenity may have issued materially misleading business information to the investing public.

PROG EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Progenity, Inc. – PROG

SAN DIEGO, Aug. 18, 2020 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against Progenity, Inc.

PROG Alert: Johnson Fistel Launches Investigation into Progenity, Inc.; Investors Suffering Losses Encouraged to Contact Firm

Progenity's (PROG) CEO Harry Stylli on Q2 2020 Results - Earnings Call Transcript

Completed initial public offering raising gross proceeds of $100M

Progenity Provides Corporate Updates and Reports Second Quarter 2020 Financial Results

The Company has established and continues to make significant investments in industry-leading compliance protocols and reporting standards The Company has established and continues to make significant investments in industry-leading compliance protocols and reporting standards

Progenity Reaches Resolution with Government Related to Past Business, Promotional, and Billing Practices

Biotech Progenity Inc. priced its initial public offering on Friday at $15 share, the midpoint of its price range.

News for Progenity Stock (PROG)